These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 26524472)

  • 41. In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.
    Lowery JJ; Raymond TJ; Giuvelis D; Bidlack JM; Polt R; Bilsky EJ
    J Pharmacol Exp Ther; 2011 Mar; 336(3):767-78. PubMed ID: 21118955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
    Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
    J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and Pharmacological Evaluation of Novel C-8 Substituted Tetrahydroquinolines as Balanced-Affinity Mu/Delta Opioid Ligands for the Treatment of Pain.
    Nastase AF; Griggs NW; Anand JP; Fernandez TJ; Harland AA; Trask TJ; Jutkiewicz EM; Traynor JR; Mosberg HI
    ACS Chem Neurosci; 2018 Jul; 9(7):1840-1848. PubMed ID: 29677442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Translation of structure-activity relationships from cyclic mixed efficacy opioid peptides to linear analogues.
    Anand JP; Porter-Barrus VR; Waldschmidt HV; Yeomans L; Pogozheva ID; Traynor JR; Mosberg HI
    Biopolymers; 2014 Jan; 102(1):107-14. PubMed ID: 24436042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
    Giri AK; Apostol CR; Wang Y; Forte BL; Largent-Milnes TM; Davis P; Rankin D; Molnar G; Olson KM; Porreca F; Vanderah TW; Hruby VJ
    J Med Chem; 2015 Nov; 58(21):8573-83. PubMed ID: 26465170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dual Pharmacophores Explored via Structure-Activity Relationship (SAR) Matrix: Insights into Potent, Bifunctional Opioid Ligand Design.
    Nastase AF; Anand JP; Bender AM; Montgomery D; Griggs NW; Fernandez TJ; Jutkiewicz EM; Traynor JR; Mosberg HI
    J Med Chem; 2019 Apr; 62(8):4193-4203. PubMed ID: 30916966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.
    Sally EJ; Xu H; Dersch CM; Hsin LW; Chang LT; Prisinzano TE; Simpson DS; Giuvelis D; Rice KC; Jacobson AE; Cheng K; Bilsky EJ; Rothman RB
    Synapse; 2010 Apr; 64(4):280-8. PubMed ID: 19953652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice.
    Guo XH; Fairbanks CA; Stone LS; Loh HH
    Pain; 2003 Jul; 104(1-2):209-17. PubMed ID: 12855331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration.
    Stevenson GW; Giuvelis D; Cormier J; Cone K; Atherton P; Krivitsky R; Warner E; St Laurent B; Dutra J; Bidlack JM; Szabò L; Polt R; Bilsky EJ
    Psychopharmacology (Berl); 2020 Apr; 237(4):1195-1208. PubMed ID: 31912192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.
    Lei W; Vekariya RH; Ananthan S; Streicher JM
    J Pain; 2020; 21(1-2):146-160. PubMed ID: 31201990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ring-constrained orvinols as analogs of buprenorphine: differences in opioid activity related to configuration of C(20) hydroxyl group.
    Traynor JR; Guo L; Coop A; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1093-9. PubMed ID: 10565829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-affinity carbamate analogues of morphinan at opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1508-11. PubMed ID: 17276685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.
    Yuan Y; Zaidi SA; Elbegdorj O; Aschenbach LC; Li G; Stevens DL; Scoggins KL; Dewey WL; Selley DE; Zhang Y
    J Med Chem; 2013 Nov; 56(22):9156-69. PubMed ID: 24144240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
    Baumann MH; Majumdar S; Le Rouzic V; Hunkele A; Uprety R; Huang XP; Xu J; Roth BL; Pan YX; Pasternak GW
    Neuropharmacology; 2018 May; 134(Pt A):101-107. PubMed ID: 28807672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.
    Purington LC; Pogozheva ID; Traynor JR; Mosberg HI
    J Med Chem; 2009 Dec; 52(23):7724-31. PubMed ID: 19788201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA
    Li G; Nieman AN; Mian MY; Zahn NM; Mikulsky BN; Poe MM; Methuku KR; Liu Y; Cook JM; Stafford DC; Arnold LA
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon.
    DiCello JJ; Carbone SE; Saito A; Rajasekhar P; Ceredig RA; Pham V; Valant C; Christopoulos A; Veldhuis NA; Canals M; Massotte D; Poole DP
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):465-483. PubMed ID: 31759144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for
    Obeng S; Wilkerson JL; León F; Reeves ME; Restrepo LF; Gamez-Jimenez LR; Patel A; Pennington AE; Taylor VA; Ho NP; Braun T; Fortner JD; Crowley ML; Williamson MR; Pallares VLC; Mottinelli M; Lopera-Londoño C; McCurdy CR; McMahon LR; Hiranita T
    J Pharmacol Exp Ther; 2021 Mar; 376(3):410-427. PubMed ID: 33384303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.